U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 91

Variation
Gene
(Protein Change)
Type
(Consequence)
ConditionClassification, Review status
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GLikely benign
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GBenign
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(synonymous variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GConflicting classifications of pathogenicity
SGCB
Single nucleotide variant
(synonymous variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
GLikely benign
SGCB
Single nucleotide variant
(synonymous variant)
not provided
+2 more
GConflicting classifications of pathogenicity
SGCB
Single nucleotide variant
(synonymous variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GConflicting classifications of pathogenicity
LOC129992585, SGCB
(E10G)
Single nucleotide variant
(missense variant)
Autosomal recessive limb-girdle muscular dystrophy type 2E
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(intron variant)
not provided
+2 more
GConflicting classifications of pathogenicity
SGCB
(A251V)
Single nucleotide variant
(missense variant)
Autosomal recessive limb-girdle muscular dystrophy type 2E
+2 more
GUncertain significance
LOC129992585, SGCB
Single nucleotide variant
(5 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GConflicting classifications of pathogenicity
LOC129992585, SGCB
Single nucleotide variant
Qualitative or quantitative defects of beta-sarcoglycan
+2 more
GUncertain significance
LOC129992585, SGCB
Single nucleotide variant
(5 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
LOC129992585, SGCB
Single nucleotide variant
(5 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+2 more
GBenign/Likely benign
SGCB, LOC129992585
Single nucleotide variant
(5 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
LOC129992585, SGCB
Single nucleotide variant
(5 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(intron variant)
Qualitative or quantitative defects of beta-sarcoglycan
+2 more
GConflicting classifications of pathogenicity
SGCB
Single nucleotide variant
(synonymous variant)
Qualitative or quantitative defects of beta-sarcoglycan
+2 more
GConflicting classifications of pathogenicity
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+2 more
GBenign
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+2 more
GConflicting classifications of pathogenicity
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+2 more
GConflicting classifications of pathogenicity
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GConflicting classifications of pathogenicity
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+2 more
GBenign
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+2 more
GBenign
SGCB
Duplication
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Deletion
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Microsatellite
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GLikely benign
SGCB
Single nucleotide variant
(3 prime UTR variant)
not provided
+2 more
GBenign
SGCB
Deletion
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GConflicting classifications of pathogenicity
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+2 more
GConflicting classifications of pathogenicity
SGCB
Deletion
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(3 prime UTR variant)
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
Qualitative or quantitative defects of beta-sarcoglycan
+1 more
GUncertain significance
SGCB
Single nucleotide variant
(synonymous variant)
Autosomal recessive limb-girdle muscular dystrophy type 2E
+2 more
GConflicting classifications of pathogenicity
SGCB
(I166V)
Single nucleotide variant
(missense variant)
not specified
+4 more
GUncertain significance
SGCB
(M168V)
Single nucleotide variant
(missense variant)
not provided
+2 more
GUncertain significance
SGCB
(R131Q)
Single nucleotide variant
(missense variant)
Autosomal recessive limb-girdle muscular dystrophy type 2E
+3 more
GUncertain significance
LOC129992585, SGCB
(Q11*)
Single nucleotide variant
(nonsense)
Autosomal recessive limb-girdle muscular dystrophy type 2E
+3 more
GPathogenic/Likely pathogenic
SGCB
(R267C)
Single nucleotide variant
(missense variant)
not specified
+4 more
GConflicting classifications of pathogenicity
LOC129992585, SGCB
Deletion
(frameshift variant +1 more)
Qualitative or quantitative defects of beta-sarcoglycan
+2 more
GPathogenic/Likely pathogenic
LOC129992585, SGCB
(Q11E)
Single nucleotide variant
(missense variant)
Qualitative or quantitative defects of beta-sarcoglycan
+3 more
GConflicting classifications of pathogenicity
SGCB
(G315R)
Single nucleotide variant
(missense variant)
Limb-girdle muscular dystrophy, recessive
+4 more
GConflicting classifications of pathogenicity
SGCB
Single nucleotide variant
(missense variant)
Primary dilated cardiomyopathy
+4 more
GConflicting classifications of pathogenicity
SGCB
Single nucleotide variant
(missense variant)
Inborn genetic diseases
+3 more
GPathogenic/Likely pathogenic
Format
Items per page
Sort by
Choose Destination